Ascend Wellness Holdings (AAWH) Share-based Compensation Growth (3y) (2023 - 2026)
Ascend Wellness Holdings (AAWH) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | -70.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -51.80% |
| Mar 31, 2026 | 65.10% |
| Sep 30, 2025 | 44.57% |
| Jun 30, 2025 | -53.91% |
| Dec 31, 2024 | 29.37% |
| Sep 30, 2024 | -49.41% |
| Jun 30, 2024 | 60.37% |
| Mar 31, 2024 | 62.72% |
| Dec 31, 2023 | 157.68% |
| Sep 30, 2023 | 480.32% |
| Mar 31, 2023 | -18.54% |